Gout is often thought of as a disease of men, but women develop gout too. Risk rises particularly after menopause. For the broader context, see who gets gout and why risk differs, and genetics and family history for another major contributor that applies across sexes.
Why is gout less common before menopause?
Estrogen appears to promote urate excretion, so premenopausal women generally have lower serum urate than men of the same age. As estrogen levels fall after menopause, serum urate and gout risk rise.
Do women get different symptoms?
The same core symptoms occur: sudden severe joint pain, swelling, warmth and redness. Older women may have more comorbidities, kidney disease or diuretic use, which can affect both presentation and treatment options.
Does hormone therapy prevent gout?
Hormones influence urate biology, but hormone therapy should not be used as a gout treatment. Decisions about menopausal hormone therapy involve many benefits and risks unrelated to gout.
Why diagnosis may be delayed
Because gout is stereotyped as a male disease, it may be overlooked in women with a red swollen joint. CPPD, rheumatoid arthritis and infection also remain important alternatives.
Treatment
Core gout treatment principles are the same: manage acute inflammation appropriately and, when indicated, lower serum urate to target so crystal deposits dissolve over time.
This article is educational and is not a substitute for medical advice.
Sources
Evidence checked September 2026.